Status:
COMPLETED
Inflammatory Mediators Associated With Infection by Respiratory Syncytial Virus
Lead Sponsor:
Uppsala University
Collaborating Sponsors:
Swedish University of Agricultural Sciences
Conditions:
Respiratory Tract Infections
Respiratory Syncytial Virus Infections
Eligibility:
All Genders
Brief Summary
Infection with human respiratory syncytial (RS) virus is the most common cause of hospital stay due to pediatric lower respiratory tract infection. An exaggerated immune response contributes to the pa...
Eligibility Criteria
Inclusion
- Admission to pediatric intensive care unit
- Clinical need for invasive ventilation
- Clinical need for intravascular catheterization
- Clinical need for urine bladder catheterization
- Patients with verified or suspected RS-virus-infection or no respiratory tract infection (control group)
Exclusion
- • Chronic inflammatory lung disease
Key Trial Info
Start Date :
April 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2022
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT03757429
Start Date
April 1 2018
End Date
April 1 2022
Last Update
May 31 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Akademiska sjukhuset, Centraloperation
Uppsala, Sweden, 75185